Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer

In addition to conventional clinicopathological parameters, molecular markers are also required in order to predict the course of disease in patients with urothelial bladder cancer (BC). Little is known about fibroblast growth factor receptor 3 (FGFR3) immunoreactivity and the clinical significance...

Descripción completa

Detalles Bibliográficos
Autores principales: POYET, CÉDRIC, HERMANNS, THOMAS, ZHONG, QING, DRESCHER, EVA, EBERLI, DANIEL, BURGER, MAXIMILIAN, HOFSTAEDTER, FERDINAND, HARTMANN, ARNDT, STÖHR, ROBERT, ZWARTHOFF, ELLEN C., SULSER, TULLIO, WILD, PETER J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665170/
https://www.ncbi.nlm.nih.gov/pubmed/26722237
http://dx.doi.org/10.3892/ol.2015.3691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665170/
https://www.ncbi.nlm.nih.gov/pubmed/26722237
http://dx.doi.org/10.3892/ol.2015.3691

Ejemplares similares